Flagship Harbor Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $461K | Sell |
4,324
-88
| -2% | -$9.38K | 0.03% | 404 |
|
2023
Q4 | $439K | Sell |
4,412
-125
| -3% | -$12.4K | 0.03% | 391 |
|
2023
Q3 | $469K | Buy |
4,537
+526
| +13% | +$54.3K | 0.04% | 348 |
|
2023
Q2 | $487K | Sell |
4,011
-4,336
| -52% | -$527K | 0.04% | 343 |
|
2023
Q1 | $1.28M | Buy |
8,347
+1,398
| +20% | +$215K | 0.12% | 186 |
|
2022
Q4 | $1.25M | Buy |
6,949
+2,412
| +53% | +$433K | 0.13% | 185 |
|
2022
Q3 | $536K | Sell |
4,537
-626
| -12% | -$74K | 0.06% | 294 |
|
2022
Q2 | $737K | Buy |
5,163
+196
| +4% | +$28K | 0.08% | 252 |
|
2022
Q1 | $856K | Sell |
4,967
-328
| -6% | -$56.5K | 0.08% | 241 |
|
2021
Q4 | $1.35M | Sell |
5,295
-647
| -11% | -$164K | 0.13% | 185 |
|
2021
Q3 | $1.4M | Hold |
5,942
| – | – | 0.15% | 157 |
|
2021
Q2 | $1.4M | Sell |
5,942
-2,121
| -26% | -$498K | 0.15% | 157 |
|
2021
Q1 | $1.06M | Buy |
8,063
+706
| +10% | +$92.5K | 0.12% | 188 |
|
2020
Q4 | $769K | Sell |
7,357
-2,240
| -23% | -$234K | 0.1% | 223 |
|
2020
Q3 | $678K | Buy |
9,597
+2,625
| +38% | +$185K | 0.09% | 211 |
|
2020
Q2 | $447K | Buy |
6,972
+1,051
| +18% | +$67.4K | 0.07% | 275 |
|
2020
Q1 | $177K | Buy |
5,921
+4,664
| +371% | +$139K | 0.04% | 415 |
|
2019
Q4 | $25K | Buy |
1,257
+720
| +134% | +$14.3K | ﹤0.01% | 1035 |
|
2019
Q3 | $8K | Buy |
537
+125
| +30% | +$1.86K | ﹤0.01% | 1346 |
|
2019
Q2 | $6K | Hold |
412
| – | – | ﹤0.01% | 1444 |
|
2019
Q1 | $8K | Buy |
412
+132
| +47% | +$2.56K | ﹤0.01% | 1363 |
|
2018
Q4 | $4K | Buy |
+280
| New | +$4K | ﹤0.01% | 1499 |
|